US Patent 9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Patent 9637453 was granted and assigned to FORMA Therapeutics on May, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+407 characters)
Article
Patent abstract
The present invention is directed to inhibitors of histone deacetylases (HDACs) such as HDAC6 and HDAC11, and their use in the treatment of diseases such as cell proliferative diseases (e.g., cancer), neurological (e.g., neurodegenerative disease or neurodevelopmental disease), inflammatory or autoimmune disease, infection, metabolic disease, hematologic disease, or cardiovascular disease.
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors US Patent 9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Infobox
Patent Number
0963745300
Patent Number
963745300
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
096374530
Date of Patent
May 2, 2017
0Patent Application Number
151306030
Date Filed
April 15, 2016
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
096374530
Date of Patent
May 2, 2017
0Patent Application Number
151306030
Date Filed
April 15, 2016
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09637453
Date of patent
May 2, 2017
Patent application number
15130603
Date Filed
April 15, 2016
Patent primary examiner
Find more entities like US Patent 9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
